Mealey's (July 1, 2020, 10:14 AM EDT) -- PHILADELPHIA — The Pennsylvania federal judge overseeing the Avandia multidistrict litigation on June 26 said that while there are bases for criticizing the conduct of counsel for a third-party payer plaintiff, defendant GlaxoSmithKline PLC (GSK) did not prove by clear and convincing evidence that the payer’s two attorneys acted in bad faith so as to justify sanctions against them (Allied Services Division Welfare Fund v. GlaxoSmithKline, No. 09-730, E.D. Pa.)....